- Home
- Tenders
- Guatemala
- PEDIDO No. 29535/2024 BEVACIZUMAB, SOLUCIÓN CONCENTRADA INYECTABLE 25 MG/ML, VIAL 4 ML; DE MARCA COMERCIAL "AVASTIN" CÓDIGO IGSS 10526
PEDIDO No. 29535/2024 BEVACIZUMAB, SOLUCIÓN CONCENTRADA INYECTABLE 25 MG/ML, VIAL 4 ML; DE MARCA COMERCIAL "AVASTIN" CÓDIGO IGSS 10526
Description
The contracting entity seeks to purchase Bevacizumab, solution concentrate injectable 25 mg/ml, vial 4 ml. The required brand name is Avastin. This pharmaceutical product must comply with Guatemalan h***** *********** ** ********* ** *** **** **** ****** ****** ****** ****** *** ********** ********** **** ******** *********** ************ *** **
Want to unlock the full information?
Member-only information. Become a member to access this information.
Procurement notices from more than 200 sources and banks are available here
Details
Status:
Awarded
Sectors:
33000000 - Medical equipments, pharmaceuticals and personal care products
Place of origin:
Guatemala
Places of performance:
Guatemala
Deadline:
Nov 27, 2024
Contract type:
Member-only information
Publication date:
Member-only information
Update date:
Member-only information
External documents
Member-only information
Original URL:
Member-only information
Buyers
Member-only information
Awards
Member-only information